Status:
UNKNOWN
Magnesium in Liver Cirrhosis
Lead Sponsor:
Meir Medical Center
Conditions:
LIVER CIRRHOSIS
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Several studies have shown in patients magnesium deficiency with liver cirrhosis. Patients with liver cirrhosis showed considerably reduced muscle strength and muscle magnesium. We suggest addition ...
Detailed Description
Magnesium is the fourth most abundant cation in the body and plays an important physiological role in many of its functions. There are no readily available and easy methods to assess magnesium status...
Eligibility Criteria
Inclusion
- patients with liver cirrhosis
Exclusion
- pregnant women
- Patients with acute or chronic renal failure (cr\>1.5)
- Congestive heart failure NYHA 3-4
- Patient with active cancer
- Patients with dementia or mental retardation
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01894867
Start Date
August 1 2013
Last Update
July 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
liver outpatients clinic, Meir medical center
Kfar Saba, Israel, Israel